22282-73-1

Usage

Uses

Used in Pharmaceutical Industry:
3-Fluoro-4-hydroxypyridine is used as a key intermediate in the synthesis of various pharmaceutical compounds for its ability to contribute to the development of new drugs. Its unique structure allows for the creation of molecules with specific therapeutic properties, making it a valuable asset in medicinal chemistry.
Used in Agrochemical Industry:
In the agrochemical sector, 3-Fluoro-4-hydroxypyridine is utilized as a precursor in the production of crop protection products. Its incorporation into these products can enhance their effectiveness in protecting crops from pests and diseases, thereby contributing to increased agricultural yields.
Used in Chemical Research:
3-Fluoro-4-hydroxypyridine serves as an important compound in chemical research, where it is employed to study various chemical reactions and mechanisms. Its unique properties make it a subject of interest for scientists looking to understand and exploit its reactivity and potential applications in new chemical processes.
Used in Industrial Processes:
3-FLUORO-4-HYDROXYPYRIDINE is also used in various industrial processes, where it may be involved in the manufacturing of specialty chemicals or as a component in complex chemical formulations. Its versatility and reactivity in different chemical environments make it a useful tool in the industry.

InChI:InChI=1/C5H4FNO/c6-4-3-7-2-1-5(4)8/h1-3H,(H,7,8)

Upstream product

• 458532-97-3 3-fluoro-4-pyridylboronic acid 

Downstream Products

• 1390657-64-3 tert-butyl 4-(4-((7-((3-fluoropyridin-4-yl)oxy)-4-oxo-3,4-dihydropyrido[3,4-d]pyridazin-5-yl)amino)-3-methoxyphenyl)piperazine-1-carboxylate 
• 955029-44-4 (syn)-3-fluoro-4-hydroxy-piperidine-1-carboxylic acid tert-butyl ester 

Relevant academic research and scientific papers

Oxidative hydroxylation of arylboronic acids to phenols catalyzed by copper nanoparticles ellagic acid composite

Copper nanoparticles (Cu NPs) were prepared by in situ reduction of CuSO4·5H2O using ellagic acid (EA) as the reducing agent as well as stabilizer and its catalytic activity is tested in the oxidative hydroxylation of phenylboronic acids to phenol without any added base or ligand. The synthesized Cu NPs-EA composite was characterized by UV-Vis., FT-IR, powder XRD and HRTEM analyses. The average particle size of Cu NPs is found to be in the range of 20-25 nm as evident from HRTEM and copper content is estimated to be 3.18 wt%. EA acts both as a reducing agent as well as a stabilizer for the in situ formation of Cu NPs. A small portion of Cu NPs is also found to undergo aerobic oxidation to give Cu2O NPs which does not take part in the reactions. A series of arylboronic acids are converted to the corresponding phenols in high yields at short reaction time under milder reaction conditions. It is also observed that Cu NPs-EA composite can be reused at least four times with a significant decrease in the yield.

1,4-Dihydro-4-oxo-pyridylacetamido cephalosporins and their utilization as medicinal agents for combating bacterial infections

Cephem derivatives of the formula STR1 wherein Z is 1,4-dihydro-4-oxo-1-pyridyl or the corresponding group substituted by one or more of alkyl of 1-4 carbon atoms, alkoxy of 1-4 carbon atoms, OH, F, Cl, Br, I, NO2 and NH2 ; and R is H, --OCOCH3 or -S-Het, wherein Het is 3-methyl-1,2,4-thiadiazolyl-5, 5-methyl-1,3,4-oxadiazolyl-2, 5-hydroxymethyl-1,3,4-oxadiazolyl-2, 5-methyl-1,3,4-thiadiazolyl-2, 5-hydroxymethyl-1,3,4-thiadiazolyl-2, tetrazolyl-5, 1-methyltetrazolyl-5, 1,2,3-triazolyl-4, 4-methyl-oxazolyl-2 or 1-oxidopyridinio-2, and the readily cleavable esters thereof and the physiologically acceptable salts thereof, possess anti-bacterial activity and can be prepared by reacting a 3-CH2 R-7-amino-3-cephem-4-carboxylic acid or a functional derivative thereof with a pyridone acetic acid of the formula Z-CH2 -COOH or a functional derivative thereof.